Medicalgorithmics SA Signs Letter of Intent with leading North American Health Monitoring Company to Integrate AI-Powered Software Platform with Wearable Biosensors
Warsaw, Poland – Medicalgorithmics, a global healthcare technology company, is pleased to announce signing of a letter of intent with a leading US-based health monitoring company which offers its monitoring services across North America (the name of the partner will be released as soon as it is allowed by the current contractual obligations of the new partner). This collaboration aims to integrate Medicalgorithmics’ cutting-edge AI-powered software with the company’s wearable biosensors, resulting in enhanced health monitoring capabilities, and it is part of the new US business strategy of Medicalgorithmics introduced at the point of investment by BioFund in Q4, 2022